Trulicity 1.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FQJKQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,915
Award facts
- Contract value 100% obligated
- $2,915.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $2,915.46 under a firm fixed price contract. This delivery order, which is expected to be completed by September 5, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to compete for federal medical procurement requirements. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania.
This delivery order is a child contract issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to military healthcare programs worldwide. Trulicity, a diabetes medication, exemplifies the specialized pharmaceutical products within the company's extensive portfolio supporting Defense Health Agency and other federal healthcare systems. The delivery order structure allows DLA to procure specific medications as needed while maintaining the efficiency and cost certainty of the overarching prime vendor agreement.
Quick answers
Who was awarded contract SPE2DB25FQJKQ?
SPE2DB25FQJKQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FQJKQ worth?
The government has obligated $2,915 on SPE2DB25FQJKQ.
Is contract SPE2DB25FQJKQ an order under another contract?
Yes. SPE2DB25FQJKQ is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJKQ competed?
The extent of competition for SPE2DB25FQJKQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award